The global Branded Generics Market was valued at USD 246.11 billion in 2022 and is projected to reach USD 415.8 billion in 2032, with a forecasted revenue CAGR of 6%. The market's revenue growth is primarily propelled by the increasing demand for high-quality generic medications among patients and healthcare professionals. Many governments worldwide are actively promoting the use of generic drugs to reduce healthcare costs, leading to a greater focus on prescription generic medications and contributing to the market's revenue growth.